Metabolomics profiling provides valuable insights into the underlying mechanisms of Morinda officinalis on protecting glucocorticoid-induced osteoporosis
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 166, 336-346
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (U1505226)
- Shanghai Committee of Science and Technology (14401902700)
This publication has 40 references indexed in Scilit:
- Update on Wnt signaling in bone cell biology and bone diseaseGene, 2012
- Associations of dietary polyunsaturated fatty acids with bone mineral density in elderly womenEuropean Journal of Clinical Nutrition, 2011
- Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitroBritish Journal of Pharmacology, 2011
- Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trialThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cellsBiochemical and Biophysical Research Communications, 2010
- Antiosteoporotic Activity of Anthraquinones from Morinda officinalis on Osteoblasts and OsteoclastsMolecules, 2009
- The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signalingThe FASEB Journal, 2007
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006
- Estrogen protects primary osteocytes against glucocorticoid-induced apoptosisApoptosis, 2005
- Effect of Mornidae Radix extracts on experimental osteoporosis in sciatic neurectomized micePhytotherapy Research, 2005